BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20191265)

  • 1. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
    Han YH; Park WH
    Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A superoxide anion generator, pyrogallol induces apoptosis in As4.1 cells through the depletion of intracellular GSH content.
    Park WH; Han YW; Kim SH; Kim SZ
    Mutat Res; 2007 Jun; 619(1-2):81-92. PubMed ID: 17382355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changes of intracellular H2O2 are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells.
    Han YW; Kim SZ; Kim SH; Park WH
    Biochem Pharmacol; 2007 Mar; 73(6):863-72. PubMed ID: 17174941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular glutathione levels are involved in carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone-induced apoptosis in As4.1 juxtaglomerular cells.
    Han YH; Park WH
    Int J Mol Med; 2011 Apr; 27(4):575-81. PubMed ID: 21258765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
    Park WH
    Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrogallol-induced calf pulmonary arterial endothelial cell death via caspase-dependent apoptosis and GSH depletion.
    Han YH; Park WH
    Food Chem Toxicol; 2010 Feb; 48(2):558-63. PubMed ID: 19913593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis.
    Park WH; Han YH; Kim SH; Kim SZ
    Toxicology; 2007 Jun; 235(1-2):130-9. PubMed ID: 17442475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrogallol-induced endothelial cell death is related to GSH depletion rather than ROS level changes.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Oncol Rep; 2010 Jan; 23(1):287-92. PubMed ID: 19956894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis.
    Han YH; Kim SZ; Kim SH; Park WH
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F511-20. PubMed ID: 17507598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
    Han YH; Kim SH; Kim SZ; Park WH
    Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels.
    Han YH; Kim SZ; Kim SH; Park WH
    Lung Cancer; 2008 Mar; 59(3):301-14. PubMed ID: 17920721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
    Park WH
    Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells.
    Han YH; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2008 Jun; 21(6):721-30. PubMed ID: 18506365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide.
    Han YH; Kim SZ; Kim SH; Park WH
    J Cell Biochem; 2008 Jun; 104(3):995-1009. PubMed ID: 18247324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.